Announcements

Shannon T. Kelley, General Counsel of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), filed a Form 4 on August 20, 2026, reporting a sale of 664 shares of common stock on August 17, 2026.

Neil Kumar, Chief Executive Officer and Director of BridgeBio Pharma, Inc. (NASDAQ:BBIO), filed a Form 4 on August 20, 2026, reporting sales of BridgeBio common stock on August 18 and 19, 2026, executed under a pre-established Rule 10b5-1 trading plan.

Chris Osowski, President and Chief Executive Officer of Green Plains Inc., filed a statement of changes in beneficial ownership on August 20, 2026, disclosing a disposition of common stock that occurred on August 19, 2026.

Director Lauren Cooks Levitan filed a Form 4 with the SEC on August 20, 2026, reporting the sale of 1,034 shares of e.l.f. Beauty, Inc. common stock on August 18, 2026.

Trent Lee Collins, Senior Vice President of Operations at Green Plains Inc. (NASDAQ:GPRE), filed a Form 4 on August 20, 2026, disclosing the disposition of 2,261 shares of common stock on August 19, 2026, in connection with tax withholding on a vesting restricted stock …

Philip Rivard, Senior Vice President of Business Development at Waste Connections, Inc., filed a statement of changes in beneficial ownership on August 20, 2026, disclosing a sale of common shares that took place on August 18, 2026.

M. Leroy Ball, Chief Executive Officer and Director of Koppers Holdings Inc., filed a Form 4 with the SEC on August 20, 2026, disclosing the sale of 3,000 shares of common stock on August 19, 2026.